BOLD on Nasdaq
Boundless Bio (United States)
Company in San Diego, United States.1
Price unavailable
Last updated Oct 16, 2026.
Overview
2018Founded1
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Every line of the income statement in the latest annual report, as filed.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Research and development | $44.8M | $55.3M |
| General and administrative | $18.7M | $18.0M |
| Total operating expenses | $63.6M | $73.3M |
| Loss from operations | -$63.6M | -$73.3M |
| Interest income | $5.4M | $7.9M |
| Other income (expense), net | -$2.0K | $12.0K |
| Total other income, net | $5.4M | $7.9M |
| Net loss | -$58.2M | -$65.4M |
| Unrealized gain (loss) on short-term investments | -$57.0K | $81.0K |
| Comprehensive loss | -$58.3M | -$65.3M |
| Net loss per share - basic | -$2.60 | -$3.85 |
| Net loss per share - diluted | -$2.60 | -$3.85 |
| Shares used in calculation, basic | 22.4M shares | 17.0M shares |
| Shares used in calculation, diluted | 22.4M shares | 17.0M shares |
Every line of the balance sheet in the latest annual report, as filed.5
| Period ending | 2025-12-31 | 2024-12-31 | 2024-03-31 |
|---|---|---|---|
| Cash and cash equivalents | $17.9M | $26.6M | |
| Short-term investments | $89.7M | $125.5M | |
| Prepaid expenses and other current assets | $2.0M | $2.3M | |
| Total current assets | $109.6M | $154.4M | |
| Property and equipment, net | $3.2M | $4.3M | |
| Right-of-use asset, net | $43.7M | $47.0M | |
| Restricted cash | $560.0K | $560.0K | |
| Other assets | $13.0K | $99.0K | |
| Total assets | $157.1M | $206.4M | |
| Accounts payable and accrued liabilities | $6.7M | $5.4M | |
| Accrued compensation | $2.6M | $2.8M | |
| Lease liabilities, current portion | $3.2M | ||
| Total current liabilities | $12.5M | $8.1M | |
| Lease liabilities, non-current | $45.9M | $47.6M | |
| Total liabilities | $58.4M | $55.8M | |
| Preferred stock, $0.0001 par value; 70,000 shares authorized and no shares issued and outstanding as of December 31, 2025 and December 31, 2024 | $0 | $0 | |
| Common stock, $0.0001 par value; 700,000 shares authorized, 22,407 shares issued and outstanding as of December 31, 2025; 700,000 shares authorized, 22,300 shares issued and outstanding as of December 31, 2024 | $2.0K | $2.0K | |
| Additional paid-in-capital | $358.3M | $352.0M | |
| Accumulated other comprehensive income | $64.0K | $121.0K | |
| Accumulated deficit | -$259.7M | -$201.5M | |
| Total stockholders' equity | $98.7M | $150.6M | |
| Total liabilities and stockholders' equity | $157.1M | $206.4M | |
| Preferred stock, par value | $0.00 | $0.00 | $0.00 |
| Preferred stock, shares authorized | 70.0M shares | 70.0M shares | 70.0M shares |
| Preferred stock, shares issued | 0 shares | 0 shares | |
| Preferred Stock, shares outstanding | 0 shares | 0 shares | |
| Common stock, par value | $0.00 | $0.00 | $0.00 |
| Common stock, shares authorized | 700.0M shares | 700.0M shares | 700.0M shares |
| Common stock shares issued | 22.4M shares | 22.3M shares | |
| Common stock, shares outstanding | 22.4M shares | 22.3M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$58.2M | -$65.4M |
| Stock-based compensation | $6.1M | $7.5M |
| Depreciation and amortization | $1.3M | $1.1M |
| Accretion of investments, net | -$2.6M | -$5.1M |
| Non-cash lease expense | $3.3M | $2.6M |
| Other | $102.0K | |
| Prepaid expenses and other assets | $332.0K | -$302.0K |
| Accounts payable and accrued liabilities | $1.6M | $775.0K |
| Operating lease liabilities | $1.5M | -$2.2M |
| Net cash used in operating activities | -$46.7M | -$60.8M |
| Purchases of investments | -$174.9M | -$208.5M |
| Maturities of investments | $213.2M | $184.9M |
| Purchases of property and equipment | -$546.0K | -$2.5M |
| Net cash provided by (used in) investing activities | $37.8M | -$26.1M |
| Proceeds from the issuance of common stock from initial public offering, net of discounts | $93.0M | |
| Payments of common stock offering costs | -$3.3M | |
| Proceeds from the exercise of stock options | $62.0K | |
| Proceeds from issuance of common stock under the Employee Stock Purchase Plan | $141.0K | $110.0K |
| Net cash provided by financing activities | $141.0K | $89.8M |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | -$8.7M | $2.9M |
| Change in unpaid common stock issuance costs | -$197.0K | |
| Addition to right-of-use assets obtained in exchange for lease obligation | $47.6M | |
| Decrease to right-of-use assets due to remeasurement of lease obligation | -$92.0K | |
| Vesting of early exercised stock options | $6.0K | |
| Unpaid property and equipment purchases | $400.0K |
Timeline
- 2018Founded Founded1
Recent filings
- Oct 8, 2026S-4
- Aug 31, 2026DRS
- Aug 28, 20264
- Aug 28, 20268-K
- Aug 28, 2026425
- Aug 27, 2026SCHEDULE 13G
- Aug 14, 2026SCHEDULE 13G/A
- Aug 14, 2026SCHEDULE 13G
- Aug 7, 202610-Q
- Jul 21, 20264
- Jul 16, 20264
- Jul 13, 20264
- Jul 8, 20264
- Jul 6, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
- Jul 6, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Every filing from the last three years, summarized. The full record is on SEC EDGAR.2
Links
- WikidataQ104481180
- SEC EDGARCIK 1782303
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7